Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maestro Nombela A"'
Autor:
Carlos Barreda Velázquez, M.ª José Almodóvar Carretón, Almudena Maestro Nombela, Silvia Herrero Hernández, Lucía Jamart Sánchez
Publikováno v:
FMC - Formación Médica Continuada en Atención Primaria. 23:416-419
Autor:
Maestro Nombela, Almudena, Almodóvar Carretón, María José, Saavedra Quirós, Virginia, Barreda Velázquez, Carlos, Jamart Sánchez, Lucía
Publikováno v:
Farmacia Hospitalaria, Volume: 41, Issue: 3, Pages: 410-422, Published: JUN 2017
Objective: Overactive bladder syndrome is a condition with high prevalence, which has a negative impact on patients’ quality of life. A drug with a novel mechanism of action has been recently approved: mirabegron. The objective of this study is to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______624::a32f050aefefde29d98427a4381bad35
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000300410&lng=en&tlng=en
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000300410&lng=en&tlng=en
Autor:
Almudena, Maestro Nombela, María José, Almodóvar Carretón, Virginia, Saavedra Quirós, Carlos, Barreda Velázquez, Lucía, Jamart Sánchez
Publikováno v:
Farmacia Hospitalaria v.41 n.3 2017
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Farmacia Hospitalaria, Vol 41, Iss 3, Pp 410-422 (2017)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Farmacia Hospitalaria, Vol 41, Iss 3, Pp 410-422 (2017)
Overactive bladder syndrome is a condition with high prevalence, which has a negative impact on patients' quality of life. A drug with a novel mechanism of action has been recently approved: mirabegron. The objective of this study is to review the sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2d4c0fc0da3dd8cf4f664298aadb78d4
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000300410
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000300410
Autor:
C Folguera Olias, A de Rivas Bravo, B. Menchén Viso, A Maestro Nombela, A Martín Alonso, A Sánchez Guerrero
Publikováno v:
European Journal of Hospital Pharmacy. 23:A72.1-A72
Background Multiple sclerosis (MS) involves an immune mediated process in which an abnormal response of the body’s immune system is directed against the central nervous system. For years, MS has been treated only with intravenous drugs. For this re
Autor:
E De la Piedra-Ríos, A Martín-Alonso, A De Rivas-Bravo, A Sánchez-Guerrero, A Maestro-Nombela
Publikováno v:
European Journal of Hospital Pharmacy. 22:A52.1-A52
Background Psoriasis is an inflammatory skin disease characterised by increased cell signalling via cytokines and chemokines. A wide variety of treatment options are available including systemic biological treatments such as tumour necrosis factor an
Autor:
Maestro Nombela A; Pharmacy Unit. Hospital Universitario Puerta de Hierro Majadahonda.. almudena.maestro@gmail.com., Almodóvar Carretón MJ; Pharmacy Unit. Northwest Hospital Management. Madrid.. almudena.maestro@gmail.com., Saavedra Quirós V; Pharmacy Unit. Hospital Universitario Puerta de Hierro Majadahonda.. almudena.maestro@gmail.com., Barreda Velázquez C; Pharmacy Unit. Northwest Hospital Management. Madrid.. almudena.maestro@gmail.com., Jamart Sánchez L; Pharmacy Unit. Northwest Hospital Management. Madrid.. almudena.maestro@gmail.com.
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2017 May 01; Vol. 41 (3), pp. 410-422. Date of Electronic Publication: 2017 May 01.